Maximum quantity allowed is 999
请选择数量
CAS RN: 302964-08-5 | 產品號碼: C3675
2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide
![2-[(6-Chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide No-Image](/medias/C3675.jpg?context=bWFzdGVyfHJvb3R8NDUyODd8aW1hZ2UvanBlZ3xhRGs1TDJoak15ODRPVEl3T0RNM016a3dNelkyTDBNek5qYzFMbXB3Wnd8Nzg2NTJjMjhlYzc1NjZmZDRjYWExOTgzZGZjOWJlYzIzZWVmMzg3YWY3NDg2YjMyNDBiOWQ3MDE3MmUwYjFkMg)
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準,敬請留意。
產品號碼 | C3675 |
純度/分析方法 | >98.0%(HPLC) |
分子式 / 分子量 | C__1__6H__1__3Cl__2N__5OS = 394.27 |
外觀與形狀(20°C) | Solid |
儲存條件 | Refrigerated (0-10°C) |
儲存在惰性氣體下 | Store under inert gas |
應避免的情況 | Air Sensitive,Heat Sensitive |
包裝和容器 | 1G-Glass Bottle with Plastic Insert (閲覽圖片) |
CAS RN | 302964-08-5 |
Reaxys-RN | 9869700 |
PubChem Substance ID | 468591222 |
MDL編號 | MFCD11045075 |
產品規格
Appearance | White to Light yellow powder to crystal |
Purity(HPLC) | min. 98.0 area% |
Purity(Nonaqueous Titration) | min. 96.0 % |
NMR | confirm to structure |
性質
熔點 | 280 °C |
Maximum Wavelength | 320 nm (MeOH) |
GHS
相關法規
運輸資料
HS編碼* | 2934.10-000 |
Application
A Key Synthetic Intermediate of Dasatinib
This product is a key synthetic intermediate of dasatinib (BMS-354825) which is a dual BCR/ABL and Src family tyrosine kinase inhibitor used for the treatment of chronic myelogenous leukemia (CML).
References
- Discovery of N-(2-Chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent AntitumorActivity in Preclinical Assays
- 2-Aminothiazole as a Novel Kinase Inhibitor Template. Structure-Activity Relationship Studies toward the Discovery of N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide (Dasatinib, BMS-354825) as a Potent pan-Src Kinase Inhibitor
- Cell-Based Proteome Profiling of Potential Dasatinib Targets by Use of Affinity-Based Probes
- Trace level determination and quantification of potential genotoxic impurities in dasatinib drug substance by UHPLC/infinity LC
產品文件 (部分產品的分析圖譜無法提供,敬請諒解。)
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助,請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注:該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉,您搜索的分析圖譜無法提供。